Virus: Respiratory Syncytial Viruses

Medical news and research articles

The lightbulb moment behind a potential antiviral breakthrough

An unexpected observation by a University of Queensland researcher could lead to a new treatment for deadly infectious diseases including COVID‑19, pneumonia in infants and children, or viral infections caused by Ebola and ...

New clues raise hopes for better treatment of RSV in babies

Future therapies for respiratory syncytial virus (RSV) must target both the virus and the immune response to ensure babies get the best possible outcomes, a new study by researchers at UCL and Great Ormond Street Hospital ...

Three-in-one vaccine shows promise against 'tripledemic'

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs ...

How RSV manipulates the immune response in respiratory cells

Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infections, particularly in newborns and older adults. How the virus manages to evade the immune system and what changes it triggers in infected cells ...

page 1 from 37